Treatment of rabbit intervertebral disc degeneration with co-transfection by adeno-associated virus-mediated SOX9 and osteogenic protein-1 double genes in vivo

International Journal of Molecular Medicine

Volumn 32, Issue 5, 2013, Pages 1063-1068

  Liu, Yong ^a   Ren, Shan ^a   Liu, Yong Jun ^a   Ma, Jinfeng ^a   Diao, Zezheng ^a   Yang, Deling ^a   Zhang, Xu ^a   Xi, Yongming ^a   Hu, Yougu ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Disc; Gene therapy; Op 1 gene; SOX9 gene

Indexed keywords

COLLAGEN TYPE 2; OSTEOGENIC PROTEIN 1; PROTEOGLYCAN; TRANSCRIPTION FACTOR SOX9;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IN VIVO GENE TRANSFER; INTERVERTEBRAL DISK DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSCLEROSIS; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 7; COLLAGEN TYPE II; DEPENDOVIRUS; INTERVERTEBRAL DISC DEGENERATION; PROTEOGLYCANS; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOX9 TRANSCRIPTION FACTOR;

EID: 84885044354     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1497     Document Type: Article

References (22)

1. Evans C: Potential biologic therapies for the intervertebral disc. J Bone Joint Surg Am 88 (Suppl 2): 95-98, 2006.
2. Wehling P, Schulitz K P, Robbins PD, Evans CH and Reinecke JA: Transfer of genes to chondrocytic cells of the lumbar spine. Proposal for a treatment strategy of spinal disorders by local gene therapy. Spine (Phila Pa 1976) 22: 1092-1097, 1997.
3. Sai JM, Hu YG and Wang DC: Constructing adeno-associated virus-TGFbeta3 and comparing its biological effect on proteo-glycan synthesis in dedifferentiated nucleus pulpous cells with adenovirus-TGFbeta1. Chin Med Sci J 22: 113-118, 2007.
4. Wallach C, Sobajima S, Watanabe Y., et al.: Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine (Phila Pa 1976) 28: 2331-2337, 2003.
5. Lohr F, Huang Q, Hu K., Dewhirst MW and Li CY: Systemic vector leakage and transgene expression by intratmorally injected recombinant adenovirus vectors. Clin Cancer Res 7: 3625-3628, 2 0 01.
6. Xi YM, Dong YF, Wang Z.J., Liu Y., Diao ZZ and Hu YG: Co-transfection of adeno-associated virus-mediated human vascular endothelial growth factor 165 and transforming growth factor-β1 into annulus fibrosus cells of rabbit degenerative intervertebral discs. Genet Mol Res: Feb 28, 2013 (Epub ahead of print).
7. Wallach CJ, Gilbertson LG and Kang JD: Gene therapy applications for intervertebral disc degeneration. Spine (Phila Pa 1976) 28: 93-98, 2003.
8. Xi Y, Kong J, Liu Y., et al.: Minimally invasive induction of an early lumbar disc degeneration model in rhesus monkeys. Spine (Phila Pa 1976) 38: E579-E586, 2013.
9. Nishida K, Suzuki T, Kakutani K., et al.: Gene therapy approach for disc degeneration and associated spinal disorders. Eur Spine J 17 (Suppl 4): 459-466, 2008.
10. Nishida K, Kang JD, Gilbertson L.G., et al.: Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta1 encoding gene. Spine (Phila Pa 1976) 24: 2419-2425, 1999.
11. Haro H, Grawford HC, Fingleton B, et al.: Matrix metallopro-temase-3- dependent generation of a macrophage chemoattractant in model of herniated disc resorption. J Clin Incest 105: 133-141, 2000.
12. Osada R, Ohshima H, Ishihara H., et al.: Autocrine/paracrine mechanism of insulin-like growth factor-1 secretion, and the effect of insulin-like growth factor-1 on proteoglycan synthesis in bovine intervertebral discs. J Orthop Res 14: 690-699, 1996.
13. Moon S, Nishirla K, Gilbertson L.G., et al.: Biologic response of human interverterbral disc cell to gene therapy cocktail. Spine (Phila Pa 1976) 33: 1850-1855, 2008.
14. Imai Y, Miyamoto K, An H.S., Thonar EJ, Andersson GB and Masuda K: Recombinant human osteogenic protein-1 upregulates proteoglycan metabolism of human anulus fibrosus and nucleus pulposus cells. Spine (Phila Pa 1976) 32: 1303-1309, 2007.
15. Takegami K, Thonar EJ, An H.S., Kamada H and Masuda K: Osteogentic protein-1 enhances matrix replenishment by intervertebral disc cells previously exposed to interleukin-1. Spine (Phila Pa 1976) 27: 1318-1325, 2002.
16. Masuda K, Imai Y, Okuma M., et al.: Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model. Spine (Phila Pa 1976) 31: 742-754, 2006.
17. Zhang Y, An HS, Song S, et al.: Growth factor osteogenic protein-1: differing effects on cells fron three distinct zones in the bovine intervertebral disc. Am J Phys Med Rehabil 83: 515-521, 2004.
18. Sive JI, Baird P, Jeziorsk M., Watkins A, Hoyland JA and Freemont AJ: Expression of chondrocyte markers by cells of normal and degenerate intervertebral disc. Mol Pathol 55: 91-97, 2002.
19. Paul R, Haydon RC, Cheng H.W., et al.: Potential use of S0X9 gene therapy for intcrvcrtcbral degenerative disc disease. Spine (Phila Pa 1976) 28: 755-763, 2003.
20. Gruber HE, Norton HJ, Ingram JA and Hanley EN Jr: The S0 transcription factor in the human disc: decreased immunolocal-ization with ageand disc degeneration. Spine (Phila Pa 1976) 30: 625-630, 2005.
21. Lefebvre V, Huang W, Harley V.R., Goodfellow PN and de Crombrugghe B: Sox9 is a potent activator of the chon-drocyte-specific enhancer of the proalphal(II) collagen gene. Mol Cell Biol 17: 2336-2346, 1997.
22. Shintani N and Hunziker EB: Chondrogenic differentiation of bovine synovium: bone morphogenetic proteins 2 and 7 and transforming growth factor beta1 induce the formation of different types of cartilaginous tissue. Arthritis Rheum 56: 1869-1879, 20 07.